Target intelligence / Profile preview

Nucleolar protein 56 (NOP56)

Target
NOP56
Molecular classification
Other (ribonucleoprotein complex subunit), Ribonucleoprotein, Ribosome biogenesis factor
01

Overview

Nucleolar protein 56 (NOP56) is a highly conserved nucleolar protein that functions as an essential subunit of the box C/D small nucleolar ribonucleoprotein (snoRNP) complexes, which are responsible for the 2′-O-methylation and processing of precursor ribosomal RNA (pre-rRNA)[1][2][3][4]. NOP56 is involved in the assembly and function of the 60S ribosomal subunit, as well as in ribosome biogenesis by forming a core part of the snoRNPs together with fibrillarin, NOP58, and SNU13 proteins[2][4]. It plays a vital role in the processing of rRNA and the synthesis of mature ribosomes, and thus is crucial for proper cellular protein synthesis[1][2][4]. Defects in the NOP56 gene, including expanded nucleotide repeats, are causally associated with spinocerebellar ataxia 36 (SCA36), a progressive neurodegenerative disease primarily affecting the cerebellum[3]. Abnormal NOP56 expression or function has also been reported to impact cancer progression, likely through dysregulation of ribosome biogenesis and cellular metabolism[1]. NOP56 is not considered a classical drug target such as a receptor, enzyme, or transporter; rather, it is a critical housekeeping factor for fundamental cell biological processes[1][2][3][4].

Other names
NOL5ASCA36Nucleolar protein 5Aspinocerebellar ataxia 36NOP56 ribonucleoprotein homolognucleolar protein 56NOP56 ribonucleoproteinnucleolar protein 5A (56 kDa with KKE/D repeat)
02

Biological functions

Ribosome biogenesisrRNA processingAssembly of box C/D snoRNP complexesCellular RNA modification
03

Disease associations

Neurodegenerative disease (notably spinocerebellar ataxia 36)Cancer (implicated in malignant progression and cellular dysregulation)Other (defective ribosome synthesis and neuron dysfunction)
04

Safety considerations

Disruption may impair ribosome biogenesis causing broad cellular dysfunctionexpansion mutations cause neurodegeneration
05

Biomarkers

Expanded hexanucleotide repeat in NOP56 (for spinocerebellar ataxia 36)

Beyond the preview

Go deeper on Nucleolar protein 56 (NOP56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleolar protein 56 (NOP56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call